Q2 FY2026 EarningsQ2 FY26 revenue of $55.2M was in-line with consensus ($55.4M), despite a 9% YoY decline. Profitability exceeded expectations, with Adjusted EBITDA of $14.6M and Adjusted Net Income of $7.5M beating the $5.9M consensus. Management provided Q3 revenue guidance of $54.0M–$55.0M, slightly below the previous run-rate, but FY26 guidance remains disciplined with an Adjusted EBITDA margin outlook of 26%–27%.
Overview: Definitive Healthcare(DH) the Revenue is 55.2 M (-9.14%), Miss estimate;the EBIT is 11.84 M (-24.29%), Beat estimate;the EPS is -0.05 (+28.57%), Beat estimate.